English | Español

Abbvie
Jamie Barrand | Jan 13, 2016

Enrollment underway for RA therapy clinical trials
Jamie Barrand | Jan 13, 2016

FDA grants priority review to new leukemia therapy
Jamie Barrand | Jan 8, 2016

FDA grants priority review to therapy for HCV, cirrhosis

Jamie Barrand | Jan 6, 2016

Study of follicular lymphoma combination therapy shows promise
Jamie Barrand | Dec 29, 2015

AbbVie researchers publish results of Venetoclax study
Jamie Barrand | Dec 3, 2015

FDA approves new drug application for hepatitis C therapy
Jamie Barrand | Dec 1, 2015

AbbVie launches hyperthyroidism education program
Jamie Barrand | Nov 20, 2015

AbbVie's hepatitis C drug study sees positive results

Trending
+ Technology/Innovation
Patient Daily News Service | Oct 9, 2025

Babylon Health collapse raises questions about AI claims across industries
Patient Daily | Oct 9, 2025

Medfluence Advisors Marketing Expert: 'The conversations leading into AAO-HNSF are shaping how ENT practices approach growth and engagement'
Patient Daily | Oct 9, 2025

AI takes center stage at ASCENT ENT conference, reshaping marketing and operations
+ Pharmaceuticals
Patient Daily | Oct 7, 2025

Patients Rising co-founder on 340B drug pricing program: ‘Patients are getting screwed when it comes to their collection practices’